Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new milestone.

Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

The practice of medicine has undergone an incredible, albeit incomplete, transformation over the past 50 years, moving ...

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...